Cargando…
Evaluation and management of acute high-grade immunotherapy-related neurotoxicity
Immune checkpoint inhibitor monoclonal antibodies allow the host's immune system to attack tumors, which has revolutionized cancer care over the last decade. As the use of immune checkpoint inhibitors has expanded, so have autoimmune-like complications known as immune-related adverse events. Th...
Autores principales: | Sandoval, Marcelo, Wechsler, Adriana H., Alhajji, Zahra, Viets-Upchurch, Jayne, Brock, Patricia, Lipe, Demis N., Al-breiki, Aisha, Yeung, Sai-Ching J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958505/ https://www.ncbi.nlm.nih.gov/pubmed/36851967 http://dx.doi.org/10.1016/j.heliyon.2023.e13725 |
Ejemplares similares
-
Diagnosis and management of immune‐related adverse effects of immune checkpoint therapy in the emergency department
por: Yeung, Sai‐Ching Jim, et al.
Publicado: (2020) -
Concomitant Deep Vein Thrombosis in Cancer Patients with Unsuspected Pulmonary Embolism
por: Qdaisat, Aiham, et al.
Publicado: (2022) -
Characteristics and predictors of venous thrombosis recurrence in patients with cancer and catheter‐related thrombosis
por: Lipe, Demis N., et al.
Publicado: (2022) -
Advance care planning: challenges at the emergency department of a cancer care center
por: Cruz-Carreras, Maria T., et al.
Publicado: (2017) -
Characteristics and Outcomes of Patients with Cancer Pain Placed in an Emergency Department Observation Unit
por: Krishnamani, Pavitra Parimala, et al.
Publicado: (2022)